Waterdrop (WDH) Sidoti's Year End Virtual Investor Conference summary

Business overview and strategy

• Operates three main segments: digital insurance brokerage, medical crowdfunding, and digital clinical trial solutions.

• Brokerage is the largest revenue contributor, with brands serving both mainland China and Hong Kong.

• Medical crowdfunding and charity platforms support insurance and healthcare services, creating cross-segment synergies.

• AI and data analytics drive customer acquisition, product recommendations, and operational efficiency.

• Focused on expanding both in China and internationally, including Hong Kong and Singapore.

Market landscape and growth potential

• China’s insurance market is valued at $600 billion in annual premiums, with significant growth potential.

• Only 4% of healthcare expenditure is covered by commercial insurance, leaving a large gap.

• Online brokerage penetration is low at 7%, compared to much higher rates in developed markets.

• Aging population and rising healthcare costs are expected to drive demand for insurance products.

• Company’s tech-enabled platform targets first-time buyers and supports lifetime customer needs.

Financial performance and shareholder returns

• Q3 2025 revenue reached $136 million, with insurance contributing nearly 90%.

• Net profit for Q3 2025 was over $22 million, with a 16% margin.

• Maintained positive operating cash flow for three years; cash reserves at $490 million as of September 2025.

• Semi-annual dividends and annual share buybacks have been consistently executed.

• Fifth annual buyback program underway, up to $50 million through September 2026.